Literature DB >> 33795029

Using urinary neutrophile gelatinase-associated lipocalin for prognosticate renal dysfunction in children with familial Mediterranean fever the study design: a pilot study.

Sinem Can Oksay1, Hasan Dursun2,3, Sebnem Tekin Neijmann4, Sami Hatipoglu1.   

Abstract

BACKGROUND: The most important finding that affects the prognosis in Familial Mediterranean Fever is renal amyloidosis. The aim of the present study was to analyze neutrophil gelatinase-associated lipocalin levels in the urine, and to investigate whether it may be used as an early marker for renal involvement.
METHODS: Forty attack-free children followed by diagnosis of Familial Mediterranean Fever with age range of 5 and 18 years, and 38 healthy children with similar ages and genders were enrolled into the study. Hemogram, sedimentation, C-reactive protein, urine analysis, creatinine in the spot urine, microalbumin and urinary neutrophil gelatinase-associated lipocalin levels were analyzed and evaluated statistically in the patients and controls.
RESULTS: There was not any statistically significant difference between the patient and control groups for age, gender, height and body weight. Although there was not any clinical sign of attack in the patient group, sedimentation, C-reactive protein and fibrinogen levels were significantly higher than the control group (p = 0.002, p = 0.023, and p = 0.006, respectively). Similarly, urinary neutrophil gelatinase-associated lipocalin level and urinary creatinine ratio were significantly higher in the patient group (p = 0.0001, p = 0.011, respectively). We found a positive correlation between uNGAL level and uNGAL/uCr ratio and number of attacks per year in FMF patients (r = 0.743, p = 0.001 and r = 0.516, p = 0.001; respectively).
CONCLUSIONS: Detection of significantly higher levels of urinary neutrophil gelatinase-associated lipocalin level and urinary neutrophil gelatinase-associated lipocalin level to creatinine ratio were suggested as urinary neutrophil gelatinase-associated lipocalin level as a non-invasive marker for renal involvement better than microalbumin.

Entities:  

Keywords:  Familial Mediterranean fever; Urinary neutrophil gelatinase-associated lipocalin

Mesh:

Substances:

Year:  2021        PMID: 33795029     DOI: 10.1186/s42358-021-00178-4

Source DB:  PubMed          Journal:  Adv Rheumatol        ISSN: 2523-3106


  32 in total

1.  Amyloidosis in familial Mediterranean fever. An independent genetically determined character.

Authors:  H HELLER; E SOHAR; J GAFNI; J HELLER
Journal:  Arch Intern Med       Date:  1961-04

Review 2.  Familial Mediterranean fever.

Authors:  E Ben-Chetrit; M Levy
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

Review 3.  Familial Mediterranean fever, review of the literature.

Authors:  Mansour Alghamdi
Journal:  Clin Rheumatol       Date:  2017-06-18       Impact factor: 2.980

Review 4.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

5.  MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; Y Shinar; N Zaks; D L Kastner; M Pras; E Pras
Journal:  Amyloid       Date:  1999-03       Impact factor: 7.141

Review 6.  Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients.

Authors:  Tekin Akpolat; Ozan Özkaya; Seza Özen
Journal:  Gene       Date:  2011-10-13       Impact factor: 3.688

7.  Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis.

Authors:  M Shohat; N Magal; T Shohat; X Chen; T Dagan; A Mimouni; Y Danon; R Lotan; G Ogur; A Sirin; M Schlezinger; G J Halpern; A Schwabe; D Kastner; J I Rotter; N Fischel-Ghodsian
Journal:  Eur J Hum Genet       Date:  1999-04       Impact factor: 4.246

8.  Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.

Authors:  Katia Stankovic Stojanovic; Véronique Hentgen; Soraya Fellahi; Sophie Georgin-Lavialle; Serge Amselem; Gilles Grateau; Jean-Philippe Bastard; Olivier Steichen
Journal:  Clin Biochem       Date:  2016-11-10       Impact factor: 3.281

9.  Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis.

Authors:  U Saatçi; S Ozen; S Ozdemir; A Bakkaloglu; N Besbas; R Topaloglu; S Arslan
Journal:  Eur J Pediatr       Date:  1997-08       Impact factor: 3.183

Review 10.  Familial Mediterranean Fever.

Authors:  Huri Ozdogan; Serdal Ugurlu
Journal:  Presse Med       Date:  2019-01-25       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.